Author = Ayman Mohamed Metwally
| Number of Articles: 2 | ||
| 1 | GFBR3 Promoter Methylation Is A Prognostic Indicator And Not Responding To Decitabine Treatment In Hepatocellular Carcinoma | |
| Volume 66, Issue 13, December 2023, Page 807-817 | ||
| mohamed ibrahim abou hendia; Ayman Mohamed Metwally; walaa hozayen; Ahmed Osama El-Gendy; Sabrin Abdel-Wahab; Abdel Hady A Abdel Wahab | ||
| 2 | Decitabine attenuates the anti-cancer effect of doxorubicin by repressing ECDH1 and inducing SNAI1 and BCL2 in HepG2 hepatocellular carcinoma cells. | |
| Volume 66, Issue 13, December 2023, Page 745-754 | ||
| Mohamed Abohendia; Ayman Mohamed Metwally; walaa hozayen; Ahmed O. El-Gendy; Abdel Hady A. Abdel Wahab | ||
View on SCiNiTO